JANSEN'S METAPHYSEAL CHONDRODYSPLASIA

Clinical trials for JANSEN'S METAPHYSEAL CHONDRODYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new JANSEN'S METAPHYSEAL CHONDRODYSPLASIA trials appear

Sign up with your email to follow new studies for JANSEN'S METAPHYSEAL CHONDRODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Hope for kids with Ultra-Rare bone disorder: first drug trial launches

Disease control Recruiting now

This study tests a new drug called PTH-IA for Jansen's Metaphyseal Chondrodysplasia (JMC), a very rare genetic bone disease that causes short stature, fractures, and kidney problems. The trial will include up to 12 adults and children to see if the drug is safe and can help contr…

Matched conditions: JANSEN'S METAPHYSEAL CHONDRODYSPLASIA

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control

Last updated May 07, 2026 18:40 UTC

JANSEN'S METAPHYSEAL CHONDRODYSPLASIA

Get alerted when new JANSEN'S METAPHYSEAL CHONDRODYSPLASIA trials appear

Hope for kids with Ultra-Rare bone disorder: first drug trial launches